Topekans Take Part in Trials

The Cotton O'Neil Diabetes Center is on the front lines of a new era in diabetes treatment.

"We have new therapies that are emerging and may get FDA approval in the next one to two years, but these agents are now available in Topeka for patients at no cost," said Dr. Alan Wynne, endocrinologist at the center.

Dr. Alan Wynne and his staff, nurse practitioners Gary Graf and Kelli Bradbury, are, or soon will be, involved in 18 clinical trials aiming to help just about any person with diabetes.

"We have a trial that is enrolling patients that are pediatric patients. We have a trial that is looking for type one patients on an insulin pump," Bradbury said. "It's just a very broad spectrum."

"The majority of those are new agents all together, either brand new types of insulin that work better than existing types of insulin or whole new categories and classes of oral agents," Wynne said.

Getting involved doesn't just give patients access to cutting edge treatment. It can also be a financial benefit.

"Any contact we have with the patient is at no charge to them or their insurance company," Bradbury said. "The medication is all provided free of charge and any lab work that's done is also done at no charge to them."

The medications are all investigational, but patients are closely monitored for any side effects.

"If at any time they don't want to participate, that's their right. They don't have to continue," Bradbury said.

The trials all have different eligibility requirements and time commitments. To see if you match up with one, contact the Cotton-O'Neil Diabetes and Endocrinology Research Center at (785) 368-0760. You don't currently have to be a patient at the clinic in order to take part.

For more information on the Diabetes Center, go to To learn about diabetes, visit the American Diabetes Association at

631 SW Commerce Pl. Topeka, Kansas 66615 phone: 785-272-6397 fax: 785-272-1363 email:
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 885126 -
Gray Television, Inc.